S. Africa's Aspen Pharmacare may be forced to shut down its production

Your video will begin in 5
Skip ad (0)

Members don't see these ads. Sign up or log in with Google or Twitter.
Published
South Africa's Aspen Pharmacare may be forced to shut down its production of Johnson & Johnson's single-dose COVID-19 vaccines if African countries do not place orders. According to a company executive, Aspen Pharmacare has not received any orders since the company signed initial terms for a licensing deal with Johnson & Johnson late last year.







Category
South Africa
Tags
Africa, News, southafrica, Pharmacare
Be the first to comment